SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001181431-14-037189
Filing Date
2014-11-24
Accepted
2014-11-24 17:45:48
Documents
1
Period of Report
2014-11-20

Document Format Files

Seq Description Document Type Size
1 SALE OF SHARES rrd419300.html 4  
1 SALE OF SHARES rrd419300.xml 4 3542
  Complete submission text file 0001181431-14-037189.txt   5348
Mailing Address 2200 POWELL ST SUITE 220 EMERYVILLE CA 94608
Business Address 2200 POWELL ST SUITE 220 EMERYVILLE CA 94608 510-903-3402
Adamas Pharmaceuticals Inc (Issuer) CIK: 0001328143 (see all company filings)

IRS No.: 421560076 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O AVALON MANAGEMENT LTD, LANDMARK SQ 1ST FLOOR, P.O. BOX 715, 64 EARTH CLOSE GRAND CAYMAN E9 KY1-1107
Business Address C/O AVALON MANAGEMENT LTD, LANDMARK SQ 1ST FLOOR, P.O. BOX 715, 64 EARTH CLOSE GRAND CAYMAN E9 KY1-1107 41(55)5 111 222
aeris Capital Equity Investments, L.P. (Reporting) CIK: 0001605431 (see all company filings)

State of Incorp.: E9 | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-36399 | Film No.: 141247325